Brilinta Tablets and Insulin degludec Subcutaneous
Determining the interaction of Brilinta Tablets and Insulin degludec Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ticagrelor
Brand name: Brilinta
Synonyms: Brilinta
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brilinta Tablets-Insulin detemir
- Brilinta Tablets-Insulin Detemir (Cartridges and Prefilled Syringes)
- Brilinta Tablets-Insulin Detemir (Vials)
- Brilinta Tablets-Insulin detemir Subcutaneous
- Brilinta Tablets-Insulin glargine
- Brilinta Tablets-Insulin Glargine (U-100) Cartridge Systems and Pens
- Insulin degludec Subcutaneous-Brimonidine
- Insulin degludec Subcutaneous-Brimonidine and brinzolamide ophthalmic
- Insulin degludec Subcutaneous-Brimonidine and Timolol
- Insulin degludec Subcutaneous-Brimonidine and timolol ophthalmic
- Insulin degludec Subcutaneous-Brimonidine ophthalmic
- Insulin degludec Subcutaneous-Brimonidine Tartrate eent